Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Trodelvy (Sacituzumab) Medicine in India

Buy Trodelvy (Sacituzumab) Medicine in India

Trodelvy (Sacituzumab)

Medicine name : Trodelvy

Generic name : Sacituzumab

Manufactured By : Immunomedics Inc

Indications : mTNBC

Medicine Description : Trodelvy is an antibody-drug conjugate for triple-negative breast cancer (TNBC) and urothelial cancer. It delivers a cytotoxic drug directly to cancer cells, improving efficacy. Given via IV infusion, it provides targeted therapy. Side effects include diarrhea, neutropenia, nausea, and fatigue. Blood count and gastrointestinal monitoring are essential during treatment.

Product Introduction

Trodelvy (Sacituzumab) is a targeted anticancer treatment used for certain adults with triple-negative breast cancer (TNBC) and HR-positive, HER2-negative breast cancer that has progressed after previous treatments. It is an antibody-drug conjugate that targets Trop-2, a protein commonly found on cancer cells, helping deliver an anticancer substance directly to the tumor cells.

Trodelvy (Sacituzumab) combines a monoclonal antibody that recognizes Trop-2 with an active chemotherapy component called SN-38. After binding to Trop-2 on cancer cells, the treatment is taken into the cells and releases SN-38, which interferes with DNA replication and helps damage and destroy cancer cells.

Trodelvy (Sacituzumab) is administered as an intravenous infusion by a healthcare professional according to your doctor's prescribed treatment schedule. Premedications may be given to reduce the risk of infusion-related reactions and nausea. Regular blood tests may be needed to monitor blood-cell counts and overall health. Inform your doctor about all medicines, vitamins, herbal products, or supplements you are taking before treatment.

Uses Of Trodelvy (Sacituzumab)

Treatment of Advanced Breast Cancer

Benefits Of Trodelvy

Trodelvy (Sacituzumab) is used to treat certain adults with triple-negative breast cancer (TNBC) and hormone receptor-positive, HER2-negative breast cancer that has progressed after previous treatments. By targeting the Trop-2 protein on cancer cells and delivering the active drug SN-38 directly to them, it helps damage cancer cells, slow their growth, and control disease progression.

Side Effects Of Trodelvy (Sacituzumab)

Some side effects of Trodelvy (Sacituzumab) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Trodelvy (Sacituzumab)

  • Diarrhea
  • Nausea
  • Fatigue
  • Decreased white blood cell count
  • Decreased red blood cell count
  • Hair loss
  • Constipation
  • Decreased appetite
  • Vomiting
  • Abdominal pain
How To Use Trodelvy

Trodelvy (Sacituzumab) is given as an intravenous infusion by a qualified healthcare professional according to your prescribed treatment schedule. It is usually administered on specific days within a treatment cycle, followed by a rest period. Premedications may be given before the infusion to reduce the risk of infusion-related reactions and nausea. Regular blood tests are required to monitor blood-cell counts and your response to treatment. Follow your doctor's schedule carefully and do not miss appointments.

How Trodelvy (Sacituzumab) Works

Trodelvy (Sacituzumab) is an antibody-drug conjugate that targets Trop-2, a protein commonly found on many cancer cells. After binding to Trop-2, it is taken into the cancer cell and releases SN-38, an active component that interferes with DNA replication. This damages cancer cells and helps slow their growth and survival.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Avoid or limit alcohol unless your doctor advises otherwise, as it may worsen nausea, diarrhea, dizziness, or fatigue during treatment.

PregnancyCONSULT YOUR DOCTOR

Trodelvy (Sacituzumab) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment as advised by your healthcare professional.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Trodelvy (Sacituzumab) and for the period recommended by your doctor after the final dose.

DrivingCONSULT YOUR DOCTOR

Trodelvy may cause fatigue, dizziness, nausea, or other symptoms that can affect alertness. Avoid driving or operating machinery if you feel unwell or unable to remain alert.

KidneyCAUTION

Tell your doctor if you have kidney problems before starting treatment. Your doctor will consider your condition and may monitor your overall health during treatment.

LiverCAUTION

Inform your doctor about any liver problems before treatment. Your doctor may monitor liver function and other blood-test results as appropriate.

Quick Tips
  • Attend all scheduled Trodelvy (Sacituzumab) infusions and follow your doctor's treatment schedule carefully.
  • Attend regular blood tests so your doctor can monitor blood-cell counts and identify complications early.
  • Drink adequate fluids and follow your doctor's advice if you experience diarrhea, vomiting, or reduced appetite.
  • Report fever, chills, persistent cough, or other signs of infection promptly, especially if your blood-cell counts are low.
  • Tell your doctor or nurse immediately if you develop rash, itching, dizziness, breathing difficulty, swelling, or other symptoms during or after the infusion.
  • Read More About - Trodelvy (Sacituzumab) from Pharma Five.
Faq

General Question

Trodelvy Medicine (Sacituzumab) is a prescription drug used to treat certain types of breast cancer, specifically triple-negative breast cancer (TNBC), and other cancers that have spread to other parts of the body.

Trodelvy Medicine is an antibody-drug conjugate (ADC) that targets and delivers chemotherapy directly to cancer cells. It works by binding to a specific protein called Trop-2 found on the surface of cancer cells and releasing a toxic drug to kill the cancer cells.

Trodelvy Medicine is prescribed to adults with metastatic or advanced triple-negative breast cancer (TNBC) or urothelial cancer who have previously received other treatments, including chemotherapy.

Trodelvy Medicine is given as an intravenous (IV) infusion in a healthcare setting, typically once every two weeks, based on your doctor’s instructions.

Common side effects of Trodelvy Medicine include nausea, diarrhea, fatigue, low blood cell counts (leading to increased risk of infection, bleeding, or anemia), and hair loss.

Yes, Trodelvy Medicine may cause serious side effects like severe diarrhea, infections, liver problems, or low blood cell counts. Inform your doctor immediately if any severe symptoms occur.

Trodelvy Medicine is typically taken for as long as it is effective and well-tolerated, or until your doctor recommends discontinuing treatment due to side effects or disease progression.

It is best to limit alcohol consumption while taking Trodelvy Medicine, as alcohol may worsen side effects such as nausea, dizziness, or fatigue.

No, Trodelvy Medicine may harm an unborn baby and should not be used during pregnancy. Women of childbearing potential should use effective contraception during treatment.

Yes, Trodelvy Medicine may interact with certain medications, including those that affect liver enzymes. Inform your doctor about all medicines you are taking, including over-the-counter drugs and supplements.

If you miss a dose of Trodelvy Medicine, contact your healthcare provider to reschedule your treatment. Do not try to make up for a missed dose by taking extra medication.

Trodelvy Medicine is administered through an IV infusion and does not require food intake. However, it is important to follow the healthcare provider’s instructions regarding meal timings and other dietary recommendations.

You should monitor for signs of infection, dehydration, or liver problems while taking Trodelvy. Regular blood tests and follow-ups with your healthcare provider are essential to monitor treatment effects.

Trodelvy Medicine is stored in a healthcare setting, where it is prepared for infusion. It should be kept refrigerated until it is used, as it requires specific storage conditions.

Trodelvy Medicine is available by prescription and is typically administered in a healthcare facility. Consult your doctor for details about obtaining Trodelvy and the best place for your treatment. Pharma Five assists in its procurement.